Get ahead of cancer advancements. Access the latest cancer treatment with clinical trial matching.Call +1 844 627 7246
Massive Bio specializes in finding clinical trials for childhood cancer. If your child has been diagnosed with any of the following childhood cancer subtypes, we're here to help. If you don't know which type of childhood cancer your child has, that's okay. Additional testing can help you determine an exact diagnosis.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.Access the free matching tool
At Massive Bio, we streamline cancer care. Our concierge approach to cancer treatment means you don't have to get hung up on the details. That's what we're here for.
“Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“
They have a really responsive and hard-working team. It’s a great way to explore clinical cancer trials and find alternative treatments.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.Call +1 844 627 7246
Clinical trials test the latest scientific advancements in childhood cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Childhood cancer patients might gain access to promising drugs and innovative treatments long before they're made available to the public.